BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 21090962)

  • 1. The brain-gut axis in abdominal pain syndromes.
    Mayer EA; Tillisch K
    Annu Rev Med; 2011; 62():381-96. PubMed ID: 21090962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuromodulators for Functional Gastrointestinal Disorders (Disorders of Gut-Brain Interaction): A Rome Foundation Working Team Report.
    Drossman DA; Tack J; Ford AC; Szigethy E; Törnblom H; Van Oudenhove L
    Gastroenterology; 2018 Mar; 154(4):1140-1171.e1. PubMed ID: 29274869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stress and the gut: pathophysiology, clinical consequences, diagnostic approach and treatment options.
    Konturek PC; Brzozowski T; Konturek SJ
    J Physiol Pharmacol; 2011 Dec; 62(6):591-9. PubMed ID: 22314561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Brain-Gut-Microbiotal Axis: A framework for understanding functional GI illness and their therapeutic interventions.
    Tait C; Sayuk GS
    Eur J Intern Med; 2021 Feb; 84():1-9. PubMed ID: 33423906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal Physiology and Function.
    Greenwood-Van Meerveld B; Johnson AC; Grundy D
    Handb Exp Pharmacol; 2017; 239():1-16. PubMed ID: 28176047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional findings in irritable bowel syndrome.
    Posserud I; Ersryd A; Simrén M
    World J Gastroenterol; 2006 May; 12(18):2830-8. PubMed ID: 16718806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methyl-orvinol-Dual activity opioid receptor ligand inhibits gastrointestinal transit and alleviates abdominal pain in the mouse models mimicking diarrhea-predominant irritable bowel syndrome.
    Zielińska M; Jarmuż A; Wasilewski A; Cami-Kobeci G; Husbands S; Fichna J
    Pharmacol Rep; 2017 Apr; 69(2):350-357. PubMed ID: 28187396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current concepts in functional gastrointestinal disorders.
    Kovacic K
    Curr Opin Pediatr; 2015 Oct; 27(5):619-24. PubMed ID: 26208234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The balancing act: endogenous modulation of pain in functional gastrointestinal disorders.
    Wilder-Smith CH
    Gut; 2011 Nov; 60(11):1589-99. PubMed ID: 21768212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of stress in functional gastrointestinal disorders. Evidence for stress-induced alterations in gastrointestinal motility and sensitivity.
    Mönnikes H; Tebbe JJ; Hildebrandt M; Arck P; Osmanoglou E; Rose M; Klapp B; Wiedenmann B; Heymann-Mönnikes I
    Dig Dis; 2001; 19(3):201-11. PubMed ID: 11752838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune activation in irritable bowel syndrome: can neuroimmune interactions explain symptoms?
    Hughes PA; Zola H; Penttila IA; Blackshaw LA; Andrews JM; Krumbiegel D
    Am J Gastroenterol; 2013 Jul; 108(7):1066-74. PubMed ID: 23649183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropathophysiology of irritable bowel syndrome.
    Wood JD
    J Clin Gastroenterol; 2002 Jul; 35(1 Suppl):S11-22. PubMed ID: 12184133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolving concepts in functional gastrointestinal disorders: promising directions for novel pharmaceutical treatments.
    Hunt RH; Tougas G
    Best Pract Res Clin Gastroenterol; 2002 Dec; 16(6):869-83. PubMed ID: 12473296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroanatomy of lower gastrointestinal pain disorders.
    Vermeulen W; De Man JG; Pelckmans PA; De Winter BY
    World J Gastroenterol; 2014 Jan; 20(4):1005-20. PubMed ID: 24574773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stress and visceral pain: focusing on irritable bowel syndrome.
    Fukudo S
    Pain; 2013 Dec; 154 Suppl 1():S63-S70. PubMed ID: 24021863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychoneuroimmunological approach to gastrointestinal related pain.
    Toljan K; Vrooman B
    Scand J Pain; 2017 Oct; 17():431-443. PubMed ID: 29122501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel mixed NOP/MOP agonist BU08070 alleviates pain and inhibits gastrointestinal motility in mouse models mimicking diarrhea-predominant irritable bowel syndrome symptoms.
    Sobczak M; Cami-Kobeci G; Sałaga M; Husbands SM; Fichna J
    Eur J Pharmacol; 2014 Aug; 736():63-9. PubMed ID: 24815321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cross-sectional study of nausea in functional abdominal pain: relation to mucosal mast cells and psychological functioning.
    Friesen C; Singh M; Singh V; Schurman JV
    BMC Gastroenterol; 2020 May; 20(1):144. PubMed ID: 32393272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain-gut axis in the pathogenesis of Helicobacter pylori infection.
    Budzyński J; Kłopocka M
    World J Gastroenterol; 2014 May; 20(18):5212-25. PubMed ID: 24833851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinicopathologic study of 24 cases of systemic mastocytosis involving the gastrointestinal tract and assessment of mucosal mast cell density in irritable bowel syndrome and asymptomatic patients.
    Doyle LA; Sepehr GJ; Hamilton MJ; Akin C; Castells MC; Hornick JL
    Am J Surg Pathol; 2014 Jun; 38(6):832-43. PubMed ID: 24618605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.